Literature DB >> 11727279

Coronary microembolization.

G Heusch1, R Schulz, D Baumgart, M Haude, R Erbel.   

Abstract

Atherosclerotic plaque rupture is a key event in the pathogenesis of acute coronary syndromes and during coronary interventions. Atherosclerotic plaque rupture does not always result in complete thrombotic occlusion of the entire epicardial coronary artery with subsequent acute myocardial infarction; however, in milder forms it may result in the embolization of atherosclerotic and thrombotic debris into the coronary microcirculation. The present report summarizes the available morphologic evidence for coronary microembolization in patients who died of coronary artery disease, especially sudden death. The report then goes on to address the experimental pathophysiology of coronary microembolization in animal models of acute coronary syndromes and heart failure. Finally, the report presents the available clinical evidence for coronary microembolization, highlights its key features--arrhythmias, contractile dysfunction, infarctlets and reduced coronary reserve--and addresses prevention by mechanical protection devices and glycoprotein IIb/IIIa antagonism. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11727279     DOI: 10.1053/pcad.2001.26968

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  9 in total

1.  Pathology of coronary microembolisation and no reflow.

Authors:  E Falk; L Thuesen
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

2.  Outcomes of direct stenting in patients with ST-elevated myocardial infarction.

Authors:  A Kalayci; V Oduncu; C Y Karabay; A Erkol; A C Tanalp; I H Tanboga; O Candan; C Gecmen; I A Izgi; C Kirma
Journal:  Herz       Date:  2017-06-14       Impact factor: 1.443

Review 3.  Triple antiplatelet therapy in acute coronary syndromes.

Authors:  Marco Valgimigli; Monica Minarelli
Journal:  Drugs       Date:  2011-09-10       Impact factor: 9.546

4.  The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention.

Authors:  Khalill Ramjane; Lei Han; Chang Jin
Journal:  Exp Clin Cardiol       Date:  2008

5.  Prevalence and Functional Implication of Silent Coronary Artery Disease in Marathon Runners Over 40 Years of Age: The MATCH-40 Study.

Authors:  Christopher T Lee; Skyler E Eastman; Liane A Arcinas; Chantal Y Asselin; David Cheung; Andrew Mayba; Antonia Zhu; Jacek Strzelczyk; Bruce Maycher; Brett Memauri; Iain D C Kirkpatrick; Davinder S Jassal
Journal:  CJC Open       Date:  2021-01-07

6.  Extensive coronary artery disease in a long-distance athlete: a case report.

Authors:  Vasiliki Katsi; Stergios Soulaidopoulos; Constantina Aggeli; George Latsios; Dimitrios Tousoulis; Konstantinos Toutouzas; Konstantinos Tsioufis
Journal:  J Athl Train       Date:  2020-12-22       Impact factor: 3.824

7.  A total closed chest sheep model of cardiogenic shock by percutaneous intracoronary ethanol injection.

Authors:  Mario Rienzo; Julien Imbault; Younes El Boustani; Antoine Beurton; Carolina Carlos Sampedrano; Philippe Pasdois; Mathieu Pernot; Olivier Bernus; Michel Haïssaguerre; Thierry Couffinhal; Alexandre Ouattara
Journal:  Sci Rep       Date:  2020-07-24       Impact factor: 4.379

Review 8.  A fresh look at coronary microembolization.

Authors:  Petra Kleinbongard; Gerd Heusch
Journal:  Nat Rev Cardiol       Date:  2021-11-16       Impact factor: 49.421

9.  Establishment of a Novel Mouse Model of Coronary Microembolization.

Authors:  Yuan-Yuan Cao; Zhang-Wei Chen; Jian-Guo Jia; Ao Chen; You Zhou; Yong Ye; Yan-Hua Gao; Yan Xia; Shu-Fu Chang; Jian-Ying Ma; Ju-Ying Qian; Jun-Bo Ge
Journal:  Chin Med J (Engl)       Date:  2016-12-20       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.